SLC7A8
Large neutral amino acids transporter small subunit 2 is a protein that in humans is encoded by the SLC7A8 gene.[1][2][3]
References
References
- ↑ Borsani G, Bassi MT, Sperandeo MP, De Grandi A, Buoninconti A, Riboni M, Manzoni M, Incerti B, Pepe A, Andria G, Ballabio A, Sebastio G (Mar 1999). “SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance”. Nat Genet. 21 (3): 297–301. doi:10.1038/6815. PMID 10080183.
- ↑ Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, Lloberas J, Zorzano A, Palacin M (Aug 1999). “Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids”. J Biol Chem. 274 (28): 19738–44. doi:10.1074/jbc.274.28.19738. PMID 10391915.
- ↑ “Entrez Gene: SLC7A8 solute carrier family 7 (cationic amino acid transporter, y+ system), member 8”.
Further reading
Further reading
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Rossier G, Meier C, Bauch C, et al. (2000). “LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine”. J. Biol. Chem. 274 (49): 34948–54. doi:10.1074/jbc.274.49.34948. PMID 10574970.
- Bassi MT, Sperandeo MP, Incerti B, et al. (2000). “SLC7A8, a gene mapping within the lysinuric protein intolerance critical region, encodes a new member of the glycoprotein-associated amino acid transporter family”. Genomics. 62 (2): 297–303. doi:10.1006/geno.1999.5978. PMID 10610726.
- Bröer A, Friedrich B, Wagner CA, et al. (2001). “Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains”. Biochem. J. 355 (Pt 3): 725–31. PMC 1221788. PMID 11311135.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Liu X, Charrier L, Gewirtz A, et al. (2003). “CD98 and intracellular adhesion molecule I regulate the activity of amino acid transporter LAT-2 in polarized intestinal epithelia”. J. Biol. Chem. 278 (26): 23672–7. doi:10.1074/jbc.M302777200. PMID 12716892.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Li S, Whorton AR (2005). “Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols”. J. Biol. Chem. 280 (20): 20102–10. doi:10.1074/jbc.M413164200. PMID 15769744.
- Kühne A, Kaiser R, Schirmer M, et al. (2007). “Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan”. Pharmacogenet. Genomics. 17 (7): 505–17. doi:10.1097/FPC.0b013e3280ea77cd. PMID 17558306.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH